Search and analyze individual stocks with comprehensive metrics

Star Health and Allied Insurance Company Limited

STARHEALTHInsurance

Fundamental Score

...

Star Health and Allied Insurance Company Limited Share Price & Market Analysis

Current Market Price (CMP)
456.30
No change data available
Market Cap
26.83K (Cr)
Industry
Insurance

Profitability Metrics

Poor

Return on Equity

9.37%
Poor

Return on Capital Employed

11.98%
Poor

Operating Profit Margin (5Y)

0.38%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

45.52x

Market Capitalization

26.83K (Cr)

Industry P/E

40.23x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-17.69%
Poor

YoY Quarterly Sales Growth

10.93%
Excellent

Sales Growth (5Y)

26.42%
Excellent

EPS Growth (5Y)

14.44%
Excellent

Profit Growth (5Y)

18.65%

Financial Health

Excellent

Debt to Equity

0.07x

Interest Coverage

N/A
Excellent

Free Cash Flow (5Y)

4.55K (Cr)

Ownership Structure

Good

Promoter Holding

58.04%
Good

FII Holding

13.89%
Excellent

DII Holding

21.08%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.
58.04%
Promoter Holding
26.83K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of STARHEALTH across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Consistent Growth Track Record (26.42% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Strong Profit Growth Track Record (18.65% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Conservative Debt Levels (D/E: 0.07)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Cash Generation (₹4550.48 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (58.04%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Strong Institutional Confidence (FII+DII: 34.97%)

Observation: Significant professional investor participation indicates quality recognition.

Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

6 factors identified

Below-Average Return on Equity (9.37%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Margin Pressure Concerns (0.38%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.

Premium Valuation Risk (P/E: 45.52x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Profit Decline Concern (-17.69%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the General Insurance sector...

Financial Statements

Comprehensive financial data for Star Health and Allied Insurance Company Limited

About STARHEALTH

Company Details

Symbol:STARHEALTH
Industry:Insurance
Sector:General Insurance

Market Information

Market Cap:26.83K (Cr)
P/E Ratio:45.52
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.00%

STARHEALTH Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)9.37%
Return on Capital Employed11.98%
Operating Profit Margin (5Y)0.38%
Debt to Equity Ratio0.07
Interest Coverage RatioN/A

Growth & Valuation

Sales Growth (5Y)26.42%
Profit Growth (5Y)18.65%
EPS Growth (5Y)14.44%
YoY Quarterly Profit Growth-17.69%
YoY Quarterly Sales Growth10.93%

Frequently Asked Questions

What is the current price of STARHEALTH?

STARHEALTH is currently trading at ₹456.30 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of STARHEALTH shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of STARHEALTH and what does it mean?

STARHEALTH has a P/E ratio of 45.52x compared to the industry average of 40.23x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹46 for every ₹1 of annual earnings. This is higher than the industry average, suggesting either growth premium or potential overvaluation.

How is STARHEALTH performing according to Bull Run's analysis?

STARHEALTH has a Bull Run fundamental score of 50.3/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 9.37%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does STARHEALTH belong to?

STARHEALTH operates in the Insurance industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Star Health and Allied Insurance Company Limited. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for STARHEALTH?

STARHEALTH has an ROE of 9.37%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Star Health and Allied Insurance Company Limited generates profits from shareholders' equity. An ROE of 9% means the company generates ₹9 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is STARHEALTH's debt-to-equity ratio and what does it indicate?

STARHEALTH has a debt-to-equity ratio of 0.07, which indicates conservative financing with low financial risk. This means the company has ₹7 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is STARHEALTH's dividend yield and is it a good dividend stock?

STARHEALTH offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has STARHEALTH grown over the past 5 years?

STARHEALTH has achieved 5-year growth rates of: Sales Growth 26.42%, Profit Growth 18.65%, and EPS Growth 14.44%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in STARHEALTH and why does it matter?

Promoters hold 58.04% of STARHEALTH shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.37%.

How does STARHEALTH compare with its industry peers?

STARHEALTH trades at P/E 45.52x vs industry average 40.23x, with ROE of 9.37% and ROCE of 11.98%. The stock trades at a premium to industry average, which may be justified by superior fundamentals. Peer comparison helps identify whether STARHEALTH is outperforming its competitive set in profitability, growth, and valuation metrics.

What is STARHEALTH's market capitalization and what category does it fall into?

STARHEALTH has a market capitalization of ₹26831 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for STARHEALTH?

Key ratios for STARHEALTH: ROE 9.37% (Needs improvement), ROCE 11.98%, P/E 45.52x, Debt-to-Equity 0.07, Interest Coverage N/Ax. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is STARHEALTH stock and what is its beta?

STARHEALTH has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for STARHEALTH?

STARHEALTH has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹456.30, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in STARHEALTH?

Key risks for STARHEALTH include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.07), and operational challenges. The stock has a Fundamental Score of 50.3/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Insurance include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is STARHEALTH's operating profit margin and how has it trended?

STARHEALTH has a 5-year average Operating Profit Margin (OPM) of 0.38%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is STARHEALTH's quarterly performance in terms of sales and profit growth?

STARHEALTH's recent quarterly performance shows YoY Sales Growth of 10.93% and YoY Profit Growth of -17.69%. This shows decent growth momentum in the business. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in STARHEALTH?

STARHEALTH has FII holding of 13.89% and DII holding of 21.08%, totaling 34.97% institutional ownership. This institutional participation level shows the confidence of professional money managers. Significant FII holding suggests global investor confidence and potential for index inclusion. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.